Material
N ickel is a metallic allergen causing contact dermatitis following dermal exposure (1) . Reports by the North American Contact Dermatitis Group have consistently ranked nickel as the number one allergen in frequency of positive patch test reactions. Nickel's allergy is mainly due to jewelry, piercing, and coins (2, 3) .
Allergic contact dermatitis (ACD) caused by metallic ions and other reactive haptens is a T cell-mediated inflammatory skin disease (4) (5) (6) . ACD is characterized by two phases: a sensitization phase and an elicitation phase. During the sensitization phase, skin dendritic cells (DCs) capture the metal bound to self-protein, migrate through the lymphatic vessels, and present the haptenprotein complex to naive T cells in the draining lymph node (7, 8) . Moreover, using human in vitro DC models, several groups have showed that chemical sensitizer treatment can induce phenotypic modifications with HLA-DR, CD86, CD40, CD83, and CCR7 upregulation and IL-12 and IL-8 production (9) (10) (11) (12) .
IL-12 consists of two chains (p40 and p35) covalently linked to give rise to a heterodimeric (p70) molecule. The induction and secretion of bioactive IL-12 are regulated by the independent production of p35 and p40 subunits. IL-12 is primarily produced by macrophages and DCs mainly in response to danger signals such as TLR agonists and plays a major role in IFN-g production by immune cells, driving a Th1/Tc1-type response (13) (14) (15) (16) . Many authors have demonstrated that CD8 + cytotoxic T lymphocytes are the main effector cells of ACD and observed their early recruitment in the skin postchallenge with chemical sensitizers (6, 17) . Injection of IL-12 during the sensitization phase favors CD8 + T cell differentiation and increases the ACD reaction (18) . In vivo studies also demonstrated that 2,4-dinitrofluorobenzene-mediated ACD was significantly blocked by anti-IL-12-neutralizing Abs, supporting the conclusion that IL-12 is an important effector in the pathogenesis of ACD (19) .
The secretion of free IL-12p40 and IL-12p70 by activated macrophages and DCs is dependent on the regulation of the il-12p40 promoter by an array of transcription factors including C/EBP, NFkB, AP-1, IFN regulatory factor (IRF)-1, and IRF-8 (20) (21) (22) (23) (24) (25) . IL12p35 expression is also tightly regulated both at the transcriptional and translational level (26, 27) . Specificity protein 1, AP-1, IRF-1, IRF-3, and IRF-8 have been described to play a role in the expression of human IL12A (23, 28, 29) . RNA interference experiments showed a critical requirement for the NF-kB p50 subunit in the production of IL-12 by human monocyte-derived DCs (Mo-DCs) after CD40L and IL-1 stimulation (24) . Moreover, IRF-1 (2/2) splenic DCs were markedly impaired in their ability to produce IL-12 after LPS stimulation (25) . In vivo, a defective IL-12 production was also observed in LPS-treated macrophages obtained from MAP kinase kinase 3-deficient mice (30) . All of these reports suggest that MAPKs, NF-kB, and IRF pathways are involved in the production of IL-12 by DCs.
NiSO 4 has been shown to activate both MAPK and NF-kB pathways in human Mo-DCs or in human DCs differentiated from CD34 + cells (CD34-DC) (9-11, 31, 32) . Inhibition of p38 MAPK, JNK, and ERK abrogated the upregulation of CD86, CD83, and CCR7 expression induced by NiSO 4 , whereas expression of HLA-DR and CD40 and the production of IL-6, IL-12p40, and IL-8 were mainly dependent on the NF-kB pathway (10, 11, (31) (32) (33) . Current hypothesis in the field of contact allergy suggests that nickel and other chemical sensitizers could be perceived as a danger signal by DCs, leading to MAPK and NF-kB activation and DC phenotypic modifications.
In this study, we address the question whether NiSO 4 itself or in synergy with other signals can induce the secretion of IL-12p70 in human Mo-DCs. We showed that: 1) nickel induced the production of IL-12p40; 2) IL-12p70 synthesis needed the presence of NiSO 4 and IFN-g, and both signals were also required for the expression of the p35 subunit of IL-12; and 3) the production of IL-12p70 in response to NiSO 4 and IFN-g was dependent on p38 MAPK, NF-kB, and IRF-1 activation. We also found that IRF-1 was activated in response to NiSO 4 in a STAT-1-dependent manner and played a crucial role in NiSO 4 -induced IL-12 production.
Materials and Methods

Generation of Mo-DCs
PBMCs were purified from buffy coats obtained from Etablissement Français du Sang (Ivry-Sur-Seine, France) by density centrifugation with Ficoll gradient (Eurobio, Les Ulis, France). Monocytes were isolated from the mononuclear fraction through magnetic positive selection using MiniMacs separation columns (Miltenyi Biotec, Bergish Gladbach, Germany) and anti-CD14 Abs coated on magnetic beads following the provider's instructions (Direct CD14 isolation kit, Miltenyi Biotec). Monocytes were cultured at 1 3 10 6 cells/ml in the presence of GM-CSF (550 U/ml) and IL-4 (550 U/ml) (both from Abcys, Paris, France) in RPMI 1640 containing Glutamax I FIGURE 1. Mo-DC treatment with NiSO 4 or NiSO 4 and IFN-g induced the production of IL-12. At day 5, iDCs were treated for 24 h with either NiSO 4 , IFN-g (1000 U/ml), or their association. A, IL-12p40 production after NiSO 4 addition. IL-12p40 was measured by ELISA. Results are expressed in picograms per milliliter (values are mean 6 SD of three independent experiments). B, IL-12p40 production postaddition of NiSO 4 (500 mM) and IFN-g (1000 U/ml). IL12p40 was measured by ELISA. Results are expressed in picograms per milliliter (values are mean 6 SD of three independent experiments). C, IL-12p70 production postaddition of NiSO 4 (500 mM) and IFN-g (1000 U/ml). IL-12p70 was measured by ELISA. Results are expressed in picograms per milliliter (values are mean 6 SD of three independent experiments). pp # 0.05 compared with control; † p # 0.05 compared with NiSO 4 ; ‡ p # 0.05 compared with IFN-g.
FIGURE 2
. IL12A mRNA expression induced by NiSO 4 and IFN-g in Mo-DCs. At day 5, iDC were treated for 4 or 8 h with NiSO 4 (500 mM), IFN-g (1000 U/ml), or their association. A, IL12A mRNA expression was measured using real-time PCR. Results were expressed as fold factor compared with untreated samples (control) and corrected by the expression of the housekeeping gene b-actin as described in Materials and Methods. Results are the mean of three independent experiments. B, IL12A mRNA expression was evaluated using RT-PCR. GAPDH was used as the housekeeping gene. Folds represent the ratio of the normalized intensity (intensity of IL12A band/intensity of GAPDH band) of treated cells divided by the normalized intensity of nontreated cells. Results are representative of three independent experiments. pp # 0.05.
supplemented with 10% heat-inactivated FCS, 1 mM sodium pyruvate, 0.1 mg/ml streptomycine, and 100 U/ml penicillin (RPMIc) (all from Life Technologies/ Invitrogen, Paisley, U.K. 
Chemical treatment of iDCs
Mo-DCs (at day 5) were washed three times in RPMIc, and their concentration was adjusted to 1 3 10 6 cells/ml. iDCs were stimulated or not with different concentrations of NiSO 4 (Sigma-Aldrich, St. Louis, MO) with or without IFN-g (1000 U/ml; Abcys) for the indicated time. To study the involvement of signaling pathways in IL-12 production, Mo-DCs were pretreated for 30 min with SP600125 (20 mM) or SB203580 (20 mM) for 1 h with Bay 11-7085 (3 mM) or for 2 h with Jak inhibitor I (0.5 mM) (all from Merck Chemicals, Darmstadt, Germany). N-acetylcysteine (NAC) was purchased from Sigma-Aldrich.
Western blot analysis iDCs (10 6 cells/ml) were exposed to NiSO 4 (500 mM) or IFN-g (1000 U/ml). After an adequate time of stimulation, cells were washed with ice-cold PBS. Cell lysates were prepared by resuspending cell pellet in lysis buffer [20 mM Tris (pH 7.4), 137 mM NaCl, 2 mM EDTA (pH 7.4), 1% Triton, 25 mM b-glycerophophate, 1 mM Na 3 VO 4 , 2 mM sodium pyrophosphate, 10% glycerol, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin, and 1 mg/ml pepstatin]. The homogenates were centrifugated at 15,000 rpm for 20 min at 4˚C. A total of 50 mg denaturated protein were loaded onto 12.5% SDS-PAGE gel and transferred on polyvinylidene difluoride membrane (Amersham Biosciences, Les Ulis, France). Membranes were then incubated with Abs directed against the phosphorylated forms of p38 MAPK (Thr180/Tyr182), JNK 1/2 (Thr183/ Tyr185), STAT-1 (Tyr 701), or STAT-1 (Ser 727) (all from Cell Signaling Technology, Ozyme, St-Quentin en Yvelines, France) or against IRF-1 (C-20) (Santa Cruz Biotechnology, Santa Cruz, CA). Immunoreactive bands were detected by chemiluminescence (ECL solution, Amersham Biosciences). p38 MAPK or STAT-1 were used as a loading control and revealed with Abs raised against p38 MAPK (p38 N20, Santa Cruz Biotechnology) or STAT-1 (Cell Signaling Technology, Ozyme). Bands were quantified by densitometry using the ImageQuant software. The intensity of the specific band was normalized to the intensity of loading control protein band. Folds represent the ratio of the normalized intensity of treated cells divided by the normalized intensity of nontreated cells.
Preparation of whole cell extract and DNA-affinity proteinbinding assay
Following treatment with NiSO 4 (500 mM) or IFN-g (1000 U/ml), cells were lysed in Nonidet P-40 hypertonic lysis buffer. In brief, cell pellets from 8 3 10 6 cells were resuspended in a buffer adjusted at pH 7.9 containing 0.2% Nonidet P-40, 20% glycerol, 20 mM HEPES-KOH, 420 mM NaCl, 1 mM DTT, 1 mM Na 3 VO 4 , 1 mM sodium pyrophosphate, 0.125 mM okadaic acid, 1 mM EDTA, 1 mM EGTA, 0.5 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml pepstatin and incubated at 4˚C for 30 min. Cellular debris were removed by centrifugation at 4˚C, 15,000 rpm, for 20 min. The DNA affinity FIGURE 3. NF-kB, MAPKs, and IRF-1 pathways are activated upon addition of NiSO 4 or NiSO 4 and IFN-g. A, MAPK activation after NiSO 4 or NiSO 4 and IFN-g treatment. At day 5, iDCs were treated or not for 30, 60, and 120 min with NiSO 4 (500 mM), IFN-g (1000 U/ml), or their association. Poststimulation, cells were lysed, and the level of phosphorylated p38 MAPK and JNK was evaluated by Western blotting using anti-phospho-p38 MAPK or anti-phospho-JNK Abs. The membrane was then probed with anti-p38 MAPK Ab for loading control. Folds represent the ratio of the normalized intensity (intensity of phosphorylated form of MAPK band/p38 MAPK band) of treated cells divided by the normalized intensity of nontreated cells. Results are representative of three independent experiments. B, NF-kB activation by NiSO 4 or NiSO 4 and IFN-g at 60 min. At day 5, iDCs were treated for 60 min with NiSO 4 (500 mM), IFN-g (1000 U/ml), or their association. Whole-cell extracts were prepared and incubated with either biotinylated NF-kB probes (NF-kB) or mutated NF-kB probes (NF-kB-mut) and streptavidin-agarose beads. P65 was detected by Western blotting. Results are representative of three independent experiments. C, IRF-1 activation by NiSO 4 or NiSO 4 and IFN-g at 90 min. At day 5, iDCs were treated for 90 min with NiSO 4 (500 mM), IFN-g (1000 U/ml), or their association. Whole-cell extracts were prepared and incubated with either biotinylated ISRE probes (ISRE) or mutated ISRE probes (ISRE-mut) and streptavidin-agarose beads. IRF-1 was detected by Western blotting. p38 MAPK was used as a loading control in whole-cell extracts using Western blotting and anti-p38 MAPK Ab. Results are representative of three independent experiments. N.S., nonspecific.
precipitation assay was carried out as described previously (34) . In brief, the following 59 biotin-labeled single-stranded oligonucleotides were hybridized: 59-ACT GCG AAC ATT TCG CTT TCATTT TGG-39 and 59-CCA AAATGA AAG CGA AAT GTT CGC AGT-39 (MWG Biotech, Ebersberg, Germany) according to the human IFN sequence response element (ISRE) consensus sequence from the IL-12p35 promoter. Mutated oligonucleotides (59-ACT GCG AAC ATT TCG CAA ACA TTT TGG-39 and 59-CCA AAA TGT TTG CGA AAT GTT CGC AGT-39) were used for unspecific control binding. Also, the following 59-biotin-labeled single-stranded oligonucleotides were hybridized: 59-TTG AGG GGA CTT TCC CAG G-39 and 59-CCT GGG AAA GTC CCC TCA A-39 (MWG Biotech) according to the human NF-kB consensus sequence. Mutated oligonucleotides (59-TTG AGG CGA CTT TCC CAG G-39 and 59-CCT GGG AAA GTC GCC TCA A-39) were used for unspecific control binding. DNA-binding proteins were isolated from 200 mg whole-cell extracts at 4˚C for 90 min with 2 mg double-stranded 59-biotinylated oligonucleotides coupled to 50 ml streptavidin-agarose beads (Sigma-Aldrich). Complexes were washed with the binding buffer and eluted by boiling in a reducing sample buffer. The binding proteins were separated on 8% SDS-PAGE followed by Western blot analysis using anti-IRF-1 (C20) or anti-p65 (sc109) mouse mAb (Santa Cruz Biotechnology).
Electroporation of Mo-DCs with small interfering IRF-1
At day 4 of differentiation, Mo-DCs were washed once with serum-free medium and once with PBS. Cells were then resuspended in serum-free medium at 4 3 10 7 cells/ml; 10 mg nonsilencing control small interfering RNA (siRNA) (siRDM from Qiagen, Courtaboeuf, France) or IRF-1 siRNA (siIRF-1 ON-TARGETplus SMARTpool from Thermo Scientific Dharmacon, Lafayette, CO) were transferred into 4-mm cuvettes (Bio-Rad, Marnes-La-Coquette, France) and filled up to a final volume of 100 ml with serum-free medium. The siIRF-1 ON-TARGETplus SMARTpool, which contained four individual duplexes, was chosen because it enhances siRNA specificity and reduces off-target effects. A total of 4 3 10 6 cells was added and pulsed in a GenePulser II (Bio-Rad) (300 V, 150 mF). Cells were then resuspended in complete medium with GM-CSF (550 U/ml) and IL-4 (550 U/ml) at a concentration of 10 6 cells/ml for 24 h and then treated according to different protocols.
mRNA expression using semiquantitative and real-time PCR Total RNA was extracted using TRIzol Reagent (Invitrogen, Cergy Pontoise, France) by the guanidium thiocyanate method as mentioned by the manufacturer. RNA was quantified by spectrophotometry. First-strand cDNA was synthesized from total RNA extracted in RNAse-free conditions. The reaction was performed on 2 mg total RNA with oligo(dT) primers (MWG Biotech) and 2 U AMV RT (Promega, Charbonnières-les-Bains, France). For semiquantitative PCR, the reaction was performed using 1 U Taq polymerase (QBiogen, Montréal, Canada). The number of cycles and the hybridization temperature used for the PCR were optimized for all the genes studied: GAPDH (24 cycles, 60˚C), IRF1 (30 cycles, 54˚C), and FIGURE 5. IRF-1 is needed for IL-12p40 and IL-12p70 production in response to NiSO 4 and IFN-g. At day 4 of differentiation, cells were electroporated with 10 mg siRNA random (RDM) or siRNA IRF-1. For the next 24 h, cells were incubated with GM-CSF (550 U/ml) and IL-4 (550 U/ml). Cell treatments were proceeded 24 h postelectroporation. A, Effect of IRF-1 siRNA treatment on IL-12p40 production. Cells were treated with NiSO 4 (500 mM) and IFN-g (1000 U/ml). After 24 h, IL-12p40 production was measured by ELISA. Results are expressed in pg/ml (values are mean 6 SD of three independent experiments). B, Effect of IRF-1 siRNA treatment on IL-12p70 production. Cells were treated with NiSO 4 (500 mM) and IFN-g (1000 U/ml). IL-12p70 production was measured after 24 h by ELISA. Results are expressed in picograms per milliliter (values are mean 6 SD of three independent experiments). C, IL12A mRNA (IL-12p35) expression. Cells were treated with NiSO 4 (500 mM) and IFN-g (1000 U/ml) for 8 h. IL12A mRNA expression was evaluated using RT-PCR. GAPDH was used as the housekeeping gene. Results are representative of three independent experiments. D, siRNA IRF-1 effect on IRF-1 protein levels. Cells were stimulated with IFN-g for two hours and lysed. IRF-1 expression was evaluated by Western blotting. Membrane was then probed with anti-p38 MAPK Ab for loading control. Numbers represent the ratio of the intensity of IRF-1 band/intensity of p38 MAPK band. Results are representative of three independent experiments.
IL12A (IL-12p35) (35 cycles, 59.2˚C). The specific primers used were (forward and reverse primers, respectively): GAPDH: 59-ACC ACA GTC CAT GCC ATC AC-39 and 59-TCC ACC ACC CTG TTG CTG TA-39; IRF1: 59-ACC CTG GCTAGA GAT GCA GA-39 and 59-TTT TCC CCT GCT TGT ATC G-39; and IL12A: 59-ACC ACT CCC AAA ACC TGC-39 and 59-CCA GGC AAC TCC CAT TAG-39. PCR products were visualized by addition of ethidium bromide on 1% agarose gel. GAPDH was used to control and calibrate cDNA synthesis. Fold induction represents the normalized ratio of treated samples divided by untreated samples.
Real-time PCR was performed using the SYBR Green technology on a LightCycler rapid thermal cycler (Roche Diagnostics, Meylan, France). Forward and reverse primers were each designed on a different exon of the target gene sequence, eliminating the possibility of amplifying genomic DNA. To confirm the specificity of the amplification, the PCR product was subjected to a melting curve analysis and agarose gel electrophoresis. PCR amplification was performed in duplicate in a total reaction volume of 10 ml. The reaction mixture consisted of 5 ml diluted template, 2 ml FastStart DNA MasterPLUS SYBR Green kit, and 0.5 mM forward and reverses primers. After an 8 s activation of Taq polymerase at 95˚C, amplification was proceeded for 30-45 cycles, each consisting of denaturation at 95˚C for 5 s, annealing at 60˚C for 5 s, and extension at 72˚C for 9 s. Specific primers were used in the PCR reaction mixture (forward and reverse primers, respectively): IL12A: 59-ACC ACT CCC AAA ACC TGC-39 and 59-CCA GGC AAC TCC CAT TAG-39; and b-actin: 59-GGC ATC CTC ACC CTG AAG TA-39 and 59-GCA CAC GCA GCT CAT TGT AG-39. Results were expressed as fold induction calculated using the standard curve method. b-actin was used to control and calibrate cDNA synthesis. Fold induction represents the normalized ratio of treated samples divided by untreated samples. FIGURE 6. IRF-1 is activated by NiSO 4 and regulates IL-12p40 production. A, IRF-1 activation in response to NiSO 4 at 4 and 6 h. Whole-cell extracts were prepared and incubated with biotinylated ISRE probes (ISRE) or mutated ISRE probes (ISRE-mut) and streptavidin-agarose beads. IRF-1 was detected by Western blotting. Results are representative of three independent experiments. p38 MAPK was used as a loading control in whole-cell extracts using Western blotting and anti-p38 MAPK. B, IRF1 mRNA expression in NiSO 4 or NiSO 4 -and IFN-g-treated cells. At day 5, iDCs were treated or not (control) with either NiSO 4 (500 mM), IFN-g (1000 U/ml), or their association. IRF1 mRNA expression was evaluated using RT-PCR at 2, 4, and 6 h. ELISA assay for measuring IL-12p40 and IL-12p70 production iDCs were treated with NiSO 4 with or without IFN-g for 24 h. In some experiments, cells were pretreated for 30 min with MAPK inhibitors or with Bay 11-7085 or DMSO for 1 h and then stimulated. Culture supernatants were collected after 24 h and stored at 280˚C. ELISA assays were performed according to the manufacturer's instructions (R&D Systems, Minneapolis, MN). The OD proportional to the intensity of the color was measured at 450 nM and 540 nM with a microplate reader (Thermo Labsystems-Multiskan, Philadelphia, PA). Results were expressed in picograms per milliliter. The sensitivity of the method was 31 pg/ml for IL12p40 and 7.8 pg/ml for IL-12p70 according to the manufacturer.
Data analysis
All data are represented as mean 6 SD of the mean (based on the entire population). Differences between the production of IL-12p40 or IL-12p70 in chemical-treated cells compared with respective controls were evaluated using an unpaired Student t test. p # 0.05 was considered to be statistically significant. All tests were performed using the software GraphPad Instat 3 (GraphPad, San Diego, CA).
Results
NiSO 4 triggers the production of IL-12p40 in human Mo-DC cells
In the first part of the study, we measured the production of IL-12p40 and IL-12p70 after NiSO 4 addition in Mo-DCs. iDCs were treated or not (control) with NiSO 4 (300, 400, and 500 mM) for 24 h. NiSO 4 induced the production of IL-12p40 in a concentration-dependent manner (Fig. 1A) . IL-12p40 production was significantly augmented at 300 mM when compared with control cells. A significant amount of IL-12p40 was present in untreated Mo-DCs as previously described (35) . In the same conditions, an average of 100 ng/ml IL12p40 was found after LPS addition (25 ng/ml) (data not shown). When IFN-g was added to NiSO 4 , IL-12p40 production was greatly augmented (Fig. 1B) . NiSO 4 was unable to induce the production of IL-12p70, but the concomitant presence of IFN-g and NiSO 4 induced the production of IL-12p70 in Mo-DCs (Fig. 1C) .
The presence of IFN-g in association with NiSO 4 is necessary for the expression of IL12A mRNA IL-12p70 depends on the synthesis of both p40 and p35 chains. iDCs were treated or not (control) for 4 or 8 h with NiSO 4 (500 mM), IFN-g (1000 U/ml), or their association. IL12A mRNA expression was measured using real-time PCR ( Fig. 2A ) and semiquantitative PCR (Fig. 2B) . These times of stimulation were chosen according to preliminary kinetics experiments measuring IL12A mRNA expression (data not shown). IL12A mRNA expression was chosen as a readout as there are no robust methods to measure IL-12p35 at the protein level. Results showed that very low levels of IL12A mRNA were detected when NiSO 4 or IFN-g were added. The presence of both NiSO 4 and IFN-g was necessary to induce the expression of detectable levels of IL12 mRNA. Moreover, results obtained with inhibitors of the p38 MAPK, JNK, and NF-kB pathways showed that in addition to IRF-1, other pathways are involved in IL-12 p35 mRNA expression (Supplemental Fig. 1 ).
NiSO 4 and IFN-g activate complementary signaling pathways: MAPKs, NF-kB, and IRF-1
The promoters of p35 and p40 are composed of several DNA binding sites for AP-1, NF-kB, and IRFs. These pathways have also been previously described to participate in IL-12 synthesis in DCs and macrophages (24, 25, 30) . We first evaluated the kinetics of JNK and p38 MAPK activation in iDCs stimulated by NiSO 4 , IFN-g, or their combination. Our results showed that NiSO 4 and NiSO 4 with IFN-g induced the phosphorylation of p38 MAPK and JNK at 30 min. The association of both NiSO 4 and IFN-g slightly upregulated p38 MAPK (at 30 min) and JNK phosphorylation (at 30 min and 60 min) compared with NiSO 4 alone (Fig. 3A) . Binding of the p65 subunit of NF-kB to specific NF-kB probes using a DNA-binding assay after 1 h of treatment was detected with both NiSO 4 and NiSO 4 with IFN-g (Fig. 3B) . We then assessed the binding of the transcription factor IRF-1 to specific IL-12p35 ISRE using a DNA-binding assay after 90 min of treatment with NiSO 4 and NiSO 4 with IFN-g. Results showed that IFN-g and NiSO 4 associated to IFN-g showed comparable binding of IRF-1 on specific ISRE DNA probes (Fig. 3C) . However, no binding of IRF-1 was detectable after 90 min of NiSO 4 treatment alone.
p38 MAPK, NF-kB, and IRF-1 contribute to the production of IL-12
To investigate the implication of MAPKs and NF-kB in IL-12p40 synthesis induced by NiSO 4 , we used three well-described pharmacological inhibitors: SB203580, a p38 MAPK inhibitor, SP60-0125, a JNK inhibitor, and Bay 11-7085, an NF-kB inhibitor. At day 5, cells were washed and pretreated with SB203580 (20 mM), SP600125 (20 mM) for 30 min, or Bay 11-7085 (3 mM) for 1 h and then stimulated for 24 h with NiSO 4 . These concentrations of inhibitors were not cytotoxic, and the optimal concentration for each inhibitor was determined based on preliminary experiments (data not shown). As JNK and NF-kB inhibitors were diluted in DMSO, cells were also pretreated for 1 h with DMSO (0.1%) as an internal control. Results showed that IL-12p40 production induced by NiSO 4 was mainly dependent on p38 MAPK and NF-kB pathways; this production was independent of the JNK pathway (Fig. 4) .
To investigate whether IRF-1 was critically required for IL-12 production induced by both signals, we used RNA interference to inhibit IRF-1 expression in iDCs. The levels of IL-12p40 and IL12p70 production were measured by ELISA. RNA interference experiments revealed that IRF-1 was critical for IL-12p40 and IL12p70 production induced by NiSO 4 associated to IFN-g (Fig. 5A, normalized intensity of nontreated cells. Results are representative of three independent experiments. B, STAT-1 phophorylation (p-Ser 727) in response to NiSO 4 is controlled by p38 MAPK. At day 5, iDCs were pretreated or not (control) with SB203580 at 20 mM for 30 min and then treated with NiSO 4 (500 mM) for 3 h. Cells were lysed, and the level of phosphorylation of STAT-1 (p-Ser 727) and the level of IRF-1 was evaluated by Western blotting. Membrane was then probed with STAT-1 Ab for loading control. Results are representative of three independent experiments. C, Specificity of Jak inhibitor 1 and SB203580 for Ser and Tyr STAT-1 phosphorylation, respectively. At day 5, iDCs were pretreated or not (control) with SB203580 at 20 mM for 30 min or Jak inhibitor at 0.5 mM for 2 h and then treated with NiSO 4 (500 mM) for 3 h. Cells were lysed, and the level of phosphorylated STAT-1 was evaluated by Western blotting. Membrane was then probed with STAT-1 Ab for loading control. Results are representative of two independent experiments. D, Jaks control IRF-1 expression and STAT-1 tyrosine phosphorylation induced by NiSO 4 . At day 5, iDCs were pretreated or not (control) with either DMSO or the Jak inhibitor at 0.5 mM for 2 h and then treated with NiSO 4 (500 mM) for 3 h. Cells were lysed, and the level of phosphorylation of STAT-1 (p-Tyr 701) and IRF-1 were evaluated by Western blotting. Membrane was then probed with STAT-1 Ab for loading control. Results are representative of three independent experiments. E, p38 MAPK inhibition does not control IRF-1 expression. At day 5, iDCs were pretreated or not (control) with SB203580 at 20 mM for 30 min and then treated with NiSO 4 (500 mM) for 3 h. Cells were lysed, and the level of IRF-1 was evaluated by Western blotting. Membrane was then probed with STAT-1 Ab for loading control. Results are representative of the mean of two independent experiments. 5B). Furthermore, we showed that IL12A mRNA expression induced by both signals was nearly completely abolished in the presence of IRF-1 siRNA (Fig. 5C ). Western blotting confirmed that ONTARGETplus SMARTpool siRNA (Thermo Scientific Dharmacon) directed to IRF-1 reduced the IFN-g-induced IRF-1 protein level by .70% (Fig. 5D) .
Nickel induces the expression of IRF-1 which contributes to IL-12p40 production
We then evaluated the expression of IRF-1 by NiSO 4 alone in MoDCs. Using a DNA-binding assay, we showed that NiSO 4 induced the binding of IRF-1 to specific ISRE at 4 h and 6 h (Fig. 6A) , whereas this was not the case at 120 min (Fig. 3C) . DNA-binding activity was lower in the presence of NiSO 4 compared with NiSO 4 plus IFN-g. NiSO 4 was also able to augment the expression of IRF1 at the mRNA level, suggesting an augmentation of its synthesis (Fig.  6B) . IRF-1 downregulation using IRF-1 siRNA reduced significantly IL-12p40 production by NiSO 4 , suggesting that IRF-1 participated to NiSO 4 -induced IL-12p40 production (Fig. 6C) . cells (37). Our results showed that NiSO 4 alone induced the phosphorylation of STAT-1 on both serine and tyrosine residues at 2 h. STAT-1 phosphorylation was still observed at 4 h (Fig. 7A) . Using a p38 MAPK inhibitor, we showed that p38 MAPK controlled the phosphorylation of STAT-1 on specific serine residues (Fig. 7B) . On the basis of the observed correlation between IRF-1 expression and phosphorylation of STAT1, we hypothesized that IRF-1 expression could depend on STAT-1 activation by NiSO 4 . iDCs were treated for 2 h with Jak inhibitor I at 0.5 mM or DMSO and then stimulated with NiSO 4 for 3 h. The optimal concentration of Jak inhibitor I was determined based on preliminary experiments (data not shown), and we also controlled that Jak inhibitor I and SB203580 did not affect STAT-1 serine phosphorylation and STAT-1 tyrosine phosphorylation, respectively (Fig. 7C) . Results showed that the abrogation of STAT-1 tyrosine phosphorylation completely inhibited the expression of IRF-1 induced by NiSO 4 . These results suggested that NiSO 4 activated STAT-1 tyrosine phosphorylation, leading to IRF-1 expression in Mo-DCs (Fig. 7D) . However, STAT-1 phosphorylation and IRF-1 expression were not dependent on p38 MAPK activity (Fig. 7E) . The next question was to elucidate if STAT-1 tyrosine phosphorylation resulted from a direct effect of NiSO 4 on Jak activity or through the synthesis of an intermediate factor. Indeed, type I IFNs are well-known inducers of STAT-1 tyrosine phosphorylation in Mo-DCs (38) . We found that NiSO 4 upregulated the ifn-b mRNA, but IFN-b was undetectable in the supernatants of Mo-DC treated for 24 h by NiSO 4 (data not shown). We then used puromycin, a well-known protein synthesis inhibitor. Mo-DCs were pretreated for 1 h with puromycin at 10 mM and then treated for 3 h with NiSO 4 . The optimal concentration of puromycin for protein synthesis inhibition was determined based on preliminary experiments (data not shown). We showed that STAT-1 tyrosine phosphorylation induced by NiSO 4 was not modified by puromycin, suggesting that STAT-1 phosphorylation did not depend on an intermediate product synthesized by Mo-DC in response to NiSO 4 (Fig. 8A) . IRF-1 protein expression was strongly inhibited as a consequence of puromycin treatment, showing that puromycin was an effective inhibitor of protein synthesis in the conditions used (Fig. 8A) . Preincubation of cells with NAC (a precursor of glutathione) is often used to reinforce the redox potential of cells. The optimal concentration of NAC was determined based on preliminary experiments (data not shown). We showed that pretreatment with NAC inhibited STAT-1 phosphorylation and completely abolished NiSO 4 -induced IRF-1 expression (Fig. 8B ).
Discussion
DCs are activated by danger signals such as proinflammatory cytokines, bacterial products, viruses, and chemicals. Sensitizers have also been demonstrated to induce the expression of markers related to function and maturation of DCs, the production of proinflammatory cytokines, and the phosphorylation of members of the MAPK family and NF-kB pathway, thus mimicking the effects of danger signals (9) (10) (11) (31) (32) (33) .
IL-12 is a key factor in the generation of Th1 and cytotoxic T cells (14-16), thus playing a major role in the generation of allergenspecific T cell response in ACD. In this study, we address the question if nickel, the most prevalent of all metal sensitizers (39), can trigger specific signaling pathways in DCs, leading to the production of IL-12 as previously described for danger signals.
We showed that NiSO 4 induced the production of IL-12p40 in Mo-DCs in a concentration-dependent manner. We and others have previously shown that NiSO 4 induced the production of IL-12p40 in Mo-DCs and CD34-DC (10, 11, 33) . However, NiSO 4 was not able to induce IL-12p70 production. When IFN-g was added with NiSO 4 , detectable amounts of IL-12p70 were then produced by Mo-DCs. In addition, both signals induced a high production of IL-12p40, showing an interesting synergistic effect compared with NiSO 4 alone. Our results are in accordance with other works that have previously shown that the production of IL-12p70 in Mo-DCs required the presence of two complementary signals such as LPS, IFN-g, or CD40L to induce a high amount of IL-12p70 synthesis (35, 40, 41) .
These results showed the necessity of IFN-g for high IL-12 production after NiSO 4 treatment in Mo-DCs. O'Leary et al. (42) showed that NK cells can mediate contact hypersensitivity reaction in mice with SCID or deficient in RAG2 (Rag2 2/2 ), which lack T cells (but have NKs). NK cells are present in low frequency in normal human skin, and an influx of NK cells is found in dermal and epidermal inflammatory infiltrates in human contact hypersensitivity (43) . NiSO 4 has also been described to induce the production of IFN-g in splenic NK cells (44) . We suggest that IFN-g produced by NK cells may participate to the production of IL-12 by NiSO 4 -stimulated DCs.
The production of IL-12p40 in activated professional APCs is generally in great excess over that of the p35 chain, making the latter molecule a limiting step in the formation of bioactive IL-12 (45) . As NiSO 4 alone induced a high level of IL-12p40 but not of IL-12p70, we evaluated the expression of IL12A mRNA (IL-12p35) in response to NiSO 4 and IFN-g. Our results showed that the combination of NiSO 4 and IFN-g induced a high expression of IL12A mRNA.
The regulation of both the IL-12p40 and IL12A genes is mainly controlled by AP-1, NF-kB, and IRF-1 factors (20, 23, 28, 46) . We then addressed the question of the signaling pathways involved in the regulation of IL-12p70 after NiSO 4 and IFN-g treatment. NiSO 4 has been described to activate MAPKs and NF-kB in CD34-DCs and Mo-DCs (9, 11, 32) . Our results showed that NiSO 4 provoked p38 MAPK and JNK phosphorylation and the binding of p65 on specific DNA probes in Mo-DCs. The association of NiSO 4 and IFN-g slightly augmented p38 MAPK and JNK activation compared with NiSO 4 -treated DCs. Moreover, IFN-g or NiSO 4 associated to IFN-g induced a detectable DNA-binding activity of IRF-1 at 90 min. The early activation of p38 MAPK, JNK, NF-kB, and IRF-1 by NiSO 4 and IFN-g is probably responsible for the synergistic production of IL-12p40 and IL-12p70 induced by both signals compared with NiSO 4 alone.
To investigate the implication of MAPK and NF-kB in the regulation of IL-12p40 by NiSO 4 , we used well-described pharmacological inhibitors of these pathways. Our results showed that IL12p40 production induced by NiSO 4 was dependent on p38 MAPK and NF-kB. Ade et al. (10) have recently showed that IL-12p40 production induced by NiSO 4 was inhibited by pharmacological inhibitors of p38 MAPK, JNK, and NF-kB pathways in CD34-DCs. Aiba et al. (11) have also shown an inhibition of IL-12p40 production by SB203580, a p38 MAPK inhibitor, in Mo-DCs. Moreover, in murine bone marrow-derived DCs, the production of IL-12p40 induced by CpG-DNA or PAM 3 CSK 4 depends on p38 MAPK and JNK pathways (47) .
IRF-1, which has been shown to play a crucial role in IL-12p70 production, is known to regulate IL12A gene expression after LPS and IFN-g treatment (20, 23, 28, 48) . Gabriele et al. (25) have also observed that IRF-1 (2/2) splenic DCs were markedly impaired for their ability to produce IL-12 after LPS treatment. Our results showed that both the levels of IL-12p40 and IL-12p70 were significantly inhibited when IRF-1 was downregulated by RNA silencing, suggesting a crucial role for IRF-1 in IL-12p40 and IL-12p70 production induced by NiSO 4 and IFN-g. The downregulation of IL12A mRNA expression with IRF-1 siRNA correlated with the strong inhibition of IL-12p70 production. Interestingly, we showed that NiSO 4 alone was able to induce IRF1 mRNA expression at 2 h and a DNA-binding activity of IRF-1 to ISRE after 4 h of treatment compared with 90 min for NiSO 4 and IFN-g. Downregulation of IRF-1 using siRNA significantly decreased IL-12p40 production induced by NiSO 4 . These results suggested that IRF-1 was also a key factor for IL-12p40 production in DCs in response to NiSO 4 alone. This report is the first one describing IRF-1 activation by NiSO 4 in human DCs.
IRF-1 synthesis in Mo-DCs has been described to be mainly regulated by STAT-1 in response to type I IFN (49) . When Mo-DCs were treated with NiSO 4 , we found that STAT-1 was phosphorylated on both serine and tyrosine residues. Using Jak inhibitor I, we found that NiSO 4 -induced IRF-1 expression was dependent on STAT-1 tyrosine phosphorylation. In contrast, NiSO 4 -induced STAT-1 phosphorylation on serine 727 was regulated by p38 MAPK, but p38 MAPK did not play any role in NiSO4-induced IRF-1 expression. As it is well described that TLR agonists induced type I IFN synthesis leading to STAT-1 phosphorylation, IRF-1 activation, and IL-12 production, we addressed the question of whether NiSO 4 -induced STAT-1 phosphorylation was dependent on type I IFN production. STAT-1 tyrosine phosphorylation induced by NiSO 4 was not affected by a pretreatment with puromycin, suggesting a direct activation of STAT-1 by NiSO 4 . Simon et al. (50) have shown in fibroblasts that the activation of the Jak-STAT pathway was dependent on the redox status of cells. NiSO 4 treatment can modify the redox status of human DCs in vitro, suggesting a possible link between activation of the Jak-STAT pathway by NiSO 4 and oxidative stress (51) (52) (53) (54) . We showed that NiSO 4 -induced oxidative stress could regulate STAT-1 phosphorylation and IRF-1 expression, suggesting that NiSO 4 -induced IL-12p40 production following NiSO4 treatment could be redox sensitive.
Finally, our results describe the specific signaling pathways induced by NiSO 4 for IL-12 production and found similarity with the one already described for danger signals. According to all published results on DC maturation induced by NiSO 4 (9-11, 31-33), we can speculate that NiSO 4 can be perceived by DCs as a danger signal, thus playing a double role of a hapten and a danger signal.
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